Q-omics provides the consensus-scored LINC02873 profile across patient tissues and cancer cell-line models. LINC02873 expression is associated with patient survival in 21 of 34 cancer types, with the highest sampling consensus in KICH. Among the 18 cancer types available for tumor–normal comparison, LINC02873 is differentially expressed in 9, with the highest sampling consensus in HNSC. Additionally, LINC02873 RNA expression shows 7,932 significant protein co-abundance associations, with the highest sampling consensus in GBM. Together, these results highlight KICH, HNSC, and GBM as cancer lineages where LINC02873 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC02873 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC02873 survival associations across molecular data types. LINC02873 RNA expression shows survival associations in the most cancer types (21). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC02873 RNA expression–survival associations across cancer types. High LINC02873 expression shows unfavorable associations in KICH, LUAD, UCEC and ACC, but favorable associations in UCS and ESCA. The KICH Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify KICH as the clearest survival context for LINC02873 RNA expression.
This table summarizes LINC02873 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 9. The strongest signals are observed in HNSC for RNA.
This table ranks reproducible tumor–normal expression differences for LINC02873. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC02873 shows higher tumor expression in HNSC, THCA, LUAD, COAD, PAAD and LUSC. The HNSC box plot shows higher LINC02873 RNA expression in tumor versus normal tissue (log2 FC = +0.163, t-test p < 0.001).
This table shows molecular features associated with LINC02873 in patient tissues and cancer cell lines. In patient samples, LINC02873 shows the broadest associations at the RNA and protein expression levels, with GBM recurring as the lineage with the largest associated feature set.
